Galderma
Pharmaceutical companyWikipedia
21
MENTIONS
16
EPISODES
15
PODCASTS
Search complete. 21 mentions across 16 episodes found for "Galderma".
Sep 18, 2026
Jake LabanGUEST
I do a lot of other things, too.
Jake LabanGUEST
You know, Leslie, you and I, you know, work with with Galderma.
Jake LabanGUEST
I'm excited, like very proud of some of the very important work that you and I have done together.
Jake LabanGUEST
Again, business faculty.
Jake LabanGUEST
That stuff I love.
Jake LabanGUEST
That is really what I get a thrill out of, knowing that we are lifting the tide for everyone to enjoy.
Jake LabanGUEST
Working with Galderma, I'm working with a medical supply company right now.
Jake LabanGUEST
I'm working in AI right now as well.
Mathieu RacheterGUEST
So SIX looks at the market value of shares available for trading and how actively they're traded, and then updates the index based on those criteria.
Mathieu RacheterGUEST
This year, uh, Galderma and Sandoz will replace Swisscom and Kühne+Nagel from the 21st of September.
Mathieu RacheterGUEST
And the biggest effect is that healthcare's weight, uh, rises from around 37 to roughly 41%, uh, based on our estimates.
Mathieu RacheterGUEST
So the additions, um, also change the mix within healthcare.
Mathieu RacheterGUEST
So Galderma brings exposure to skin health and aesthetics, while Sandoz adds generics and biosimilars, and these are growing markets.
Mathieu RacheterGUEST
Uh, so, uh, their inclusion should also lift the earnings growth profile of the SMI overall.
Mathieu RacheterGUEST
At the same time, uh, developments in healthcare will have an even greater influence, uh, on the index returns.
Marco ValleGUEST
And it introduced me to the world of software as a service and enterprise level software, which I'm now, that's like the world that I'm living in right now, the sort of integration of that as well as aesthetics.
Marco ValleGUEST
And then I was recruited back into the space by Galderma.
Marco ValleGUEST
and had an amazing experience there.
Marco ValleGUEST
I was at Galderma for five years.
Marco ValleGUEST
I was the US sales training manager, part of an amazing team there.
Marco ValleGUEST
I always joke, one of my little claims of fame is, If you've ever heard the Dysport brand message, the NFL message, natural looking, fast acting, long lasting, I wrote that.
Marco ValleGUEST
But I love Botox.
Marco ValleGUEST
I love all the toxins, right? We can all play well in the sandbox.
Savanna BodaHOST
Yeah.
RyanGUEST
The, the ink kind of wasn't dry on the Galderma deal with Alastin.
Savanna BodaHOST
Yeah.
RyanGUEST
And so just as a test market, but the real launch of the brand happened, and happened in the professional channel.
Amy ChangHOST
...
Amy ChangHOST
Galderma reported their first half of 2026 that their injectables business grew double digits, 13%.
Amy ChangHOST
That does include Restylane products and as well their Sculptra, which had double-digit growth.
John FrederickGUEST
Yeah.
EricHOST
So we'll start with two cases in the area of pharma, uh, two recent cases of high interest I'll talk about.
EricHOST
Uh, the first case involved, uh, Dupixent as the advertiser, and they were challenged by Galderma.
EricHOST
Um, Dupixent is a product, uh, an eczema treatment manufactured by Sanofi.
EricHOST
Uh, that's not the-- this isn't the first time we've seen these parties involved.
Justin HaiGUEST
Well, my last company was called Last In Skincare, and we were experts in developing products that would actually get into the body, so penetrate the skin and get in.
Justin HaiGUEST
Consequently, we sold it to Galderma.
Justin HaiGUEST
It's probably one of the top medical skincare lines in the world today.
Justin HaiGUEST
So we became experts at peptides, experts at delivery.
JB Samantha LobazGUEST
So I think there's been more room for other brands.
JB Samantha LobazGUEST
Definitely Galderma.
JB Samantha LobazGUEST
Revance really has like, they were the big winners this year, I feel like.
JB Samantha LobazGUEST
They were.
Jack ArmstrongHOST
yeah.
Jack ArmstrongHOST
Anyway, so here's the brilliant turnaround that Galderma, well, I may have the wrong company.
Jack ArmstrongHOST
Oh, okay, so injectable aesthetics company Evolus, brought a new hyaluronic acid injectable product line to market, but filler is out.
Jack ArmstrongHOST
So they're not going to use the word filler anymore, and they've advised their outlets and their salespeople and all to drop the F word.
Joe GettyHOST
yeah.
Joe GettyHOST
Anyway, so here's the brilliant turnaround that Galderma, well, I may have the wrong company.
Joe GettyHOST
Oh, okay, so injectable aesthetics company Evolus, brought a new hyaluronic acid injectable product line to market, but filler is out.
Joe GettyHOST
So they're not going to use the word filler anymore, and they've advised their outlets and their salespeople and all to drop the F word.
6 more episodes mention Galderma.
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.